This RSA section is an unofficial mirror, is not legal advice, and may be incomplete, outdated, or incorrectly processed.
RSA 326-B:9-a · Completion of Survey; Rulemaking
326-B:9-a Completion of Survey; Rulemaking. –
Copy linkThe board shall adopt rules, pursuant to RSA 541-A, for APRNs only requiring, as part of the license renewal process, completion by licensees of a survey or opt-out form provided by the office of rural health, department of health and human services, for the purpose of collecting data regarding the New Hampshire primary care workforce, pursuant to the commission established in RSA 126-T. Any rules adopted under this section shall provide the licensee with written notice of his or her opportunity to opt-out from participation in the survey.
Copy linkThe board shall adopt rules, pursuant to RSA 541-A, for RNs and LPNs only requiring, as part of the license renewal process, completion by licensees of a survey or opt-out form provided by the National Council of State Boards of Nursing regarding minimum data sets. Any rules adopted under this section shall provide the licensee with written notice of his or her opportunity to opt-out from participation in the survey. Source. 2017, 131:5, eff. June 16, 2017. 2019, 254:7, eff. July 1, 2019.
Copy linkSource note
Source. 2017, 131:5, eff. June 16, 2017. 2019, 254:7, eff. July 1, 2019.
Source history
- 2017, 131:5, eff. June 16, 2017
- 2019, 254:7, eff. July 1, 2019
Related materials
Bill relationships
-
2026 HB1321
reference
cian licensed under this chapter, a physician associate licensed under RSA 328-D acting within the scope of their practice, or an advanced practice registered nurse licensed under RSA 326-B acting within the scope of their practice. 329:56 Administration of Elective Intravenous Therapy. Elective intravenous therapy may only be administered by a physician licensed under this chapter, a physician associ
-
2026 HB1796
reference · effective 2027-01-01
rgeon or osteopathic physician and surgeon licensed pursuant to RSA 329, a physician associate licensed pursuant to RSA 328-D, or an advanced practice registered nurse pursuant to RSA 326-B, who is registered by the department to recommend treatment with psilocybin. XX. “Qualified therapy provider” means a physician and surgeon or osteopathic physician and surgeon licensed pursuant to RSA 329, a physic
-
2026 HB1796-FN
reference · effective 2027-01-01
rgeon or osteopathic physician and surgeon licensed pursuant to RSA 329, a physician associate licensed pursuant to RSA 328-D, or an advanced practice registered nurse pursuant to RSA 326-B, who is registered by the department to recommend treatment with psilocybin. XX. “Qualified therapy provider” means a physician and surgeon or osteopathic physician and surgeon licensed pursuant to RSA 329, a physic
-
2026 SB453
reference
d by the commissioner or his designee shall be for a period not to exceed 2 years; except in any case where a licensed physician, advanced practice registered nurse licensed under RSA 326-B, or physician associate licensed under RSA 329-D documents a lasting medical necessity, in which case the waiver shall be for a period not to exceed 4 years. The applicant may reapply for the waiver before such period e
-
2025 HB254
reference
tions to be used in medical aid in dying: (1) A physician licensed pursuant to RSA 329; (2) An osteopathic physician licensed pursuant to RSA 329; (3) An advanced practice registered nurse licensed pursuant to RSA 326-B; or (4) A pharmacist licensed pursuant to RSA 318; provided, however, that a pharmacist shall not qualify as an attending health care provider under RSA 137-M:1, II or as a consulting health care provider unde